Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. TMO
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
TMO
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

TMO Price Prediction Next Week

Based on the provided data and recent market activity, here's a comprehensive analysis for TMO's price movement in the next trading week:

Technical Analysis

  • Current price: $556.22 (as of Jan 17, 2025)
  • RSI(14) at 65.17 indicates moderate bullish momentum without being overbought
  • MACD shows positive momentum with value at 7.32
  • Price is currently trading near its 20-day SMA of $535.68 and 60-day SMA of $536.35, suggesting a neutral-to-bullish trend

News Impact Analysis

  • Negative: New export controls on biotechnology equipment announced by U.S. Commerce Department affecting TMO and other biotech companies. The stock dropped 2% on this news.
  • Positive: Potential beneficiary from Trump's anticipated policies favoring U.S. manufacturing over overseas suppliers.
  • Positive: Strong market position in healthcare and life sciences solutions sector with $204.4 billion market cap.

Price Targets for Next Week Based on Fibonacci levels:

  • Resistance levels: R1: $561.64, R2: $571.61, R3: $587.75
  • Support levels: S1: $529.35, S2: $519.38, S3: $503.23
  • Pivot: $545.49

Trading Recommendation SELL with target price range of $529-$519

Rationale:

  1. Recent negative regulatory impact from export controls likely to continue pressuring the stock
  2. Technical indicators showing potential exhaustion of current uptrend
  3. Price currently trading below recent resistance levels
  4. Multiple competitors in the sector facing similar headwinds, suggesting sector-wide pressure

Key Risk Factors

  • Potential positive surprise from Q4 earnings
  • Changes in U.S. manufacturing policies
  • Further regulatory developments
  • Market sentiment shift towards healthcare sector

The stock is likely to face downward pressure in the short term due to regulatory headwinds, though long-term fundamentals remain strong. Traders should monitor earnings announcements and regulatory news for potential catalysts.

Based on the provided data and recent market activity, here's a comprehensive analysis for TMO's price movement in the next trading week:

Technical Analysis

  • Current price: $556.22 (as of Jan 17, 2025)
  • RSI(14) at 65.17 indicates moderate bullish momentum without being overbought
  • MACD shows positive momentum with value at 7.32
  • Price is currently trading near its 20-day SMA of $535.68 and 60-day SMA of $536.35, suggesting a neutral-to-bullish trend

News Impact Analysis

  • Negative: New export controls on biotechnology equipment announced by U.S. Commerce Department affecting TMO and other biotech companies. The stock dropped 2% on this news.
  • Positive: Potential beneficiary from Trump's anticipated policies favoring U.S. manufacturing over overseas suppliers.
  • Positive: Strong market position in healthcare and life sciences solutions sector with $204.4 billion market cap.

Price Targets for Next Week Based on Fibonacci levels:

  • Resistance levels: R1: $561.64, R2: $571.61, R3: $587.75
  • Support levels: S1: $529.35, S2: $519.38, S3: $503.23
  • Pivot: $545.49

Trading Recommendation SELL with target price range of $529-$519

Rationale:

  1. Recent negative regulatory impact from export controls likely to continue pressuring the stock
  2. Technical indicators showing potential exhaustion of current uptrend
  3. Price currently trading below recent resistance levels
  4. Multiple competitors in the sector facing similar headwinds, suggesting sector-wide pressure

Key Risk Factors

  • Potential positive surprise from Q4 earnings
  • Changes in U.S. manufacturing policies
  • Further regulatory developments
  • Market sentiment shift towards healthcare sector

The stock is likely to face downward pressure in the short term due to regulatory headwinds, though long-term fundamentals remain strong. Traders should monitor earnings announcements and regulatory news for potential catalysts.

TMO Similar Chart Price Prediction

The price of TMO is predicted to go up -0.51%, based on the high correlation periods with DAL. The similarity of these two price pattern on the periods is 96.75%.

stocks logo

TMO

stocks logo

DAL

Down: -0.51%Similarity: 96.75%

TMO Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

TMO Price Forecast($)

Potential Return(%)

2025

532.740

0.140

2026

620.000

16.540

2027

750.000

40.970

2028

750.000

40.970

2029

750.000

39.620

2030

850.000

58.230

What is TMO stock price prediction 2025 ?

TMO stock is currently trading at $532.74. Based on its strong fundamentals, healthcare sector resilience, and analyst optimism with a target price of $655.48, TMO could reach $600-$650 by the end of 2025. This projection assumes steady revenue growth and recovery from recent underperformance.

What is TMO stock price prediction 2026 ?

TMO's stock price is predicted to reach approximately $620 by 2026. This projection is based on its strong fundamentals, including consistent revenue growth in the healthcare sector and its leadership in life sciences solutions. Additionally, analysts' optimism and a potential recovery from recent underperformance support this target.

What is TMO stock price prediction 2027 ?

TMO stock price prediction for 2027 is estimated to be around $750, driven by its strong position in the healthcare and life sciences sector, consistent revenue growth, and expanding market share in biopharma services. The company's focus on innovation and acquisitions is expected to sustain its competitive edge and profitability. However, macroeconomic factors and competition could influence the actual outcome.

What is TMO stock price prediction 2028 ?

Price prediction for TMO stock in 2028 is estimated at $750-$800. This projection is based on Thermo Fisher Scientific's strong fundamentals, consistent growth in healthcare and life sciences sectors, and its ability to maintain competitive advantages through innovation and acquisitions. Additionally, the company's valuation metrics and historical performance suggest a steady upward trajectory over the long term.

What is TMO stock price prediction 2029 ?

TMO stock is projected to reach approximately $750 by 2029, driven by consistent growth in the life sciences sector and its strong market position. This estimate assumes a compound annual growth rate (CAGR) of around 6% from its current price, supported by Thermo Fisher's robust R&D investments and expanding biopharma services. However, potential risks include regulatory challenges and competitive pressures that could impact profitability.

What is TMO stock price prediction 2030 ?

TMO's stock price prediction for 2030 is estimated at $850. This projection is based on its strong position in the healthcare and life sciences sector, consistent revenue growth, and expanding market demand for advanced diagnostics and biopharma services. Additionally, its historical performance and valuation trends support this long-term growth outlook.

TMO Revenue Forecast

TMO EPS Forecast

TMO FAQs

What is bull’s view on TMO?

TMO stock has a bullish outlook with a price target of $660 by analysts like BofA Securities and Wells Fargo, reflecting a 25% upside. This optimism is driven by improving core growth, stable market conditions, and strong balance sheet optionality. Additionally, RBC Capital's $718 target highlights bioproduction momentum and resilience in key segments.

What is bear's view on TMO?

TMO stock shows bearish signals as it trades at $532.78, down 15% from its 52-week high of $627.88. Weak revenue growth in key segments and margin contraction have raised concerns about profitability. Additionally, TMO is underperforming its peers and broader indices, indicating limited near-term upside.

What is TMO revenue forecast for next quarter？

The market consensus for TMO's revenue in the upcoming quarter is projected to be approximately $10.688B USD.

What is TMO eps forecast for next quarter？

The market consensus for TMO's eps in the upcoming quarter is projected to be approximately $5.375 USD.

TMO VS S&P500

Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilence.

PPD business is growing above-market rates, implying share gains. The company's scale and reach have boosted performance in this already-attractive business.

Thermo Fisher is successfully implementing price hikes within its portfolio, offsetting inflation pressures.

Ask Intellectia about TMO

TMO Analyst's Forecast

Sung Ji Nam

Scotiabank

Hold

Price Target

$605

Upside

+15.17%

Scotiabank initiated coverage of Thermo Fisher with a Sector Perform rating and $605 price target as the firm began coverage of three life science tools and diagnostics companies.
Eve Burstein

Bernstein

Hold

Price Target

$625 → $620

Upside

+11.25%

Conor McNamara

RBC Capital

Buy

Price Target

$767 → $718

Upside

+28.84%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free